Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy
暂无分享,去创建一个
Yang Song | Guangxu Lan | Wenbin Lin | Xiaopin Duan | Kaiyuan Ni | Yang Song | Xiaopin Duan | Wenbin Lin | Kaiyuan Ni | Samuel S. Veroneau | Samuel S Veroneau | Guangxu Lan
[1] J. Haveman,et al. Clonogenic assay of cells in vitro , 2006, Nature Protocols.
[2] R. Weichselbaum,et al. Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy. , 2016, Journal of the American Chemical Society.
[3] William Dowhan,et al. Visualization of Phospholipid Domains inEscherichia coli by Using the Cardiolipin-Specific Fluorescent Dye 10-N-Nonyl Acridine Orange , 2000, Journal of bacteriology.
[4] G. Steele,et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[5] T. Omura,et al. Mitochondria-targeting sequence, a multi-role sorting sequence recognized at all steps of protein import into mitochondria. , 1998, Journal of biochemistry.
[6] Walter Neupert,et al. Why Do We Still Have a Maternally Inherited Mitochondrial DNA ? Insights from Evolutionary Medicine , 2007 .
[7] Ping Yu,et al. Mitochondria Targeted Nanoscale Zeolitic Imidazole Framework-90 for ATP Imaging in Live Cells. , 2017, Journal of the American Chemical Society.
[8] A. Moor,et al. Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.
[9] Qian Peng,et al. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. , 2006, Journal of photochemistry and photobiology. B, Biology.
[10] R. Gurny,et al. State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.
[11] Michael R Hamblin,et al. Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.
[12] Lei Wang,et al. Metal–Organic Framework@Porous Organic Polymer Nanocomposite for Photodynamic Therapy , 2017 .
[13] Demin Liu,et al. Nanoscale Metal–Organic Frameworks for the Co-Delivery of Cisplatin and Pooled siRNAs to Enhance Therapeutic Efficacy in Drug-Resistant Ovarian Cancer Cells , 2014, Journal of the American Chemical Society.
[14] L. Ji,et al. Ruthenium(II) anthraquinone complexes as two-photon luminescent probes for cycling hypoxia imaging in vivo. , 2015, Biomaterials.
[15] Bhuvan Unhelkar,et al. Strategies and Applications , 2011 .
[16] Wenbin Lin,et al. Nanoscale Metal–Organic Framework for Highly Effective Photodynamic Therapy of Resistant Head and Neck Cancer , 2014, Journal of the American Chemical Society.
[17] Michael O’Keeffe,et al. The Chemistry and Applications of Metal-Organic Frameworks , 2013, Science.
[18] Guangxia Shen,et al. Light‐Triggered Theranostics Based on Photosensitizer‐Conjugated Carbon Dots for Simultaneous Enhanced‐Fluorescence Imaging and Photodynamic Therapy , 2012, Advanced materials.
[19] F. Cordelières,et al. A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.
[20] Wenbin Lin,et al. Nanoscale Metal–Organic Frameworks for Real-Time Intracellular pH Sensing in Live Cells , 2014, Journal of the American Chemical Society.
[21] E. Ruoslahti,et al. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[22] N. Chandel,et al. Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia , 2000, The Journal of Biological Chemistry.
[23] J C Reed,et al. Mitochondria and apoptosis. , 1998, Science.
[24] C. Gomer,et al. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.
[25] P. L. La Riviere,et al. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy , 2018, Nature Communications.
[26] P. Stang,et al. Heterometallic Ru–Pt metallacycle for two-photon photodynamic therapy , 2018, Proceedings of the National Academy of Sciences.
[27] T. Cheng,et al. Structure‐Guided Design and Synthesis of a Mitochondria‐Targeting Near‐Infrared Fluorophore with Multimodal Therapeutic Activities , 2017, Advanced materials.
[28] Jong Hwa Jung,et al. Enhanced NIR radiation-triggered hyperthermia by mitochondrial targeting. , 2015, Journal of the American Chemical Society.
[29] S. Dhar,et al. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics , 2012, Proceedings of the National Academy of Sciences.
[30] Chulhong Kim,et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. , 2011, Nature materials.
[31] S. Dhar,et al. Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy. , 2013, ACS nano.
[32] T. Gunnlaugsson,et al. The development of ruthenium(ii) polypyridyl complexes and conjugates for in vitro cellular and in vivo applications. , 2017, Chemical Society reviews.
[33] K. Berg,et al. THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.
[34] Chad A Mirkin,et al. Nucleic acid-metal organic framework (MOF) nanoparticle conjugates. , 2014, Journal of the American Chemical Society.
[35] Chih-Ching Wu,et al. Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets , 2003, Journal of cellular physiology.
[36] J. Long,et al. Olsalazine-Based Metal-Organic Frameworks as Biocompatible Platforms for H2 Adsorption and Drug Delivery. , 2016, Journal of the American Chemical Society.
[37] Zhe-Sheng Chen,et al. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials. , 2017, Chemical Society reviews.
[38] Wenbin Lin,et al. Nanoscale Metal-Organic Layers for Deeply Penetrating X-ray-Induced Photodynamic Therapy. , 2017, Angewandte Chemie.
[39] D. Kessel,et al. Photodynamic therapy: A mitochondrial inducer of apoptosis , 1999, Cell Death and Differentiation.
[40] Charles Pelizzari,et al. Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy , 2018, Nature Biomedical Engineering.
[41] Hui Chao,et al. Two-photon luminescent metal complexes for bioimaging and cancer phototherapy , 2016 .
[42] David Kessel,et al. Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.
[43] Wenbin Lin,et al. Nanoscale Metal-Organic Frameworks for Phototherapy of Cancer. , 2017, Coordination chemistry reviews.
[44] Guanying Li,et al. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents. , 2015, Biomaterials.
[45] Xian‐Zheng Zhang,et al. π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis. , 2018, ACS nano.
[46] Liming Nie,et al. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. , 2016, Chemical Society reviews.
[47] Á. Villanueva,et al. MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets. , 2012, Acta histochemica.
[48] K. Johnson. An Update. , 1984, Journal of food protection.
[49] M. C. Mancini,et al. Bioimaging: second window for in vivo imaging. , 2009, Nature nanotechnology.
[50] Michael R Hamblin,et al. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.
[51] S. Dhar,et al. Detouring of cisplatin to access mitochondrial genome for overcoming resistance , 2014, Proceedings of the National Academy of Sciences.
[52] J. Joseph,et al. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. , 2017, Chemical reviews.
[53] Tayyaba Hasan,et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.
[54] L. Galluzzi,et al. Organelle-specific initiation of cell death , 2014, Nature Cell Biology.
[55] S. Kelley,et al. Targeting Mitochondria with Organelle‐Specific Compounds: Strategies and Applications , 2009, Chembiochem : a European journal of chemical biology.
[56] L. Spiccia,et al. Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid. , 2012, Journal of the American Chemical Society.